Experimental study of relationship between hypertension and tumor growth and metastases. by Fisher, E. R. et al.
342
EXPERIMENTAL STUDY OF RELATIONSHIP BETWEEN
HYPERTENSION AND TUMOR GROWTH AND METASTASES
E. R. FISHER, H. R. HELLSTROM AND B. FISHER
From the Departments ofPathology and Surgery, University ofPittsburgh School of
Medicine, and Veterans Administration Hospital, Pittsburgh, Pennsylvania, U.S.A.
Received for publication Febraury 29, 1968
THE results of several clinical studies have disclosed a dissociation between
hypertensive and neoplastic diseases, particularly in males (Foldes, 1949; Moore,
Taylor and Corcoran, 1956; Pellanda, 1964; Perry, 1963; Zondek, 1952, 1955;
and Zondek and Tchetchik, 1953). It has also been suggested that the normo-
tensive or relative hypotensive state may represent a more favourable milieu for
cancerdissemination (Pellanda, 1964). Zondek (1952) proposedthattheinanition,
anemia and elevated body temperature encountered in many patients with cancer
might exert a depressing effect on pre-existing hypertension. However, Pellanda
(1964) observed this same relationship between hypertension and cancer when
those patients with cancer that exhibited wasting were excluded from his calcula-
tions. Zondek (1955), subsequently aware of an infrequency of rheumatoid
arthritis in cancer patients, speculated that an agent such as cortisone which is
pressor but anti-inflammatory and anti-proliferative in action might play some
role in accounting for such biologic antagonisms. Pellanda (1964) related the
situation to a deficiency of mineralocorticoid activity.
The lack of experimental information concerning the possible relationship
between hypertension and tumor growth and metastases has prompted us to
investigate the effect of 2 forms ofexperimental hypertension on the subcutaneous
and hepatic growth and metastases ofthe Walker tumor in the rat.
MATERLAL AND METHODS
Female Sprague-Dawley rats weighing 180-200 g. were used in all experiments.
Animals were housed in individual cages and maintained with standard laboratory
chow and water ad libitum unless otherwise indicated.
Hypertension (blood pressure exceeding 130 mm. Hg) was successfully induced
in 94 rats by unilateral renal artery constriction with a clip fashioned from silver
ribbon. Forty-five received a subcutaneous injection of 500,000 Walker tumor
cells suspended in 0-5 ml. ofsaline intheleft lower hind limb and 49 were subjected
to an intraportal injection of 5000 Walker tumor cells 1 week after the onset of
hypertension (approximately 2 weeks after renal artery constriction). Sham-
operated anduntouched controls received similarinjections oftumor cells prepared
from the same donor tumor.
Hypertension was also induced in 49 unilaterally nephrectomized animals by
the daily subcutaneous injection of 5 mg. of deoxycorticosterone acetate (DOCA)
in 0-1 ml. of sesame oil and administration of 1% saline as drinking fluid. These
as well as unilaterally nephrectomized rats receiving injections of sesame oil only
and untreated intact animals, were injected with tumor cells as noted above.HYPERTENSION AND TUMOR GROWTH
The technics of preparation and injection of Walker tumor cells were similar
to those previously described in detail (Fisher and Fisher, 1966).
Blood pressure was estimated by a microphonic technic daily for the first week
after the initiation ofthe experiments and at subsequent weekly intervals.
Blood volume of rats with renal hypertension with and without injections of
tumor cells and untreated controls was estimated by determining the dilution of
RISA131I (Abbott Laboratories, E. Chicago, Illinois) in a 10-minute post injection
sample of 1 ml. ofblood (FisherandFisher, 1966). All animals were killed 2 weeks
following intraportal injection of tumor cells and 2 months after subcutaneous
inoculation. All organs were carefully examined for metastases and questionable
lesions verified by histologic examination. The degree ofhepatic involvement by
tumor was also estimated according to a previously described scheme (Fisher and
Fisher, 1966) in those rats subjected to intraportal injection oftumor cells.
RESULTS
The incidence of hepatic neoplasms following intraportal injection of Walker
tumor cells was greater in rats with renal hypertension than sham-operated or
untouched controls (Table I). Further, neoplastic involvement of the liver was
TABLE I.-Effect of Renal and DOCA-induced Hypertension on Hepatic Tumor Growth and
Metastases Following Intraportal Injection of Walker Tumor Cells
Blood pressure Hepatic Lung
Blood vol. ttumor metastases
No. % body wt. Initial T.TC.I.* At death % + % 2, 3 + % +
Renal artery constriction
Clip 49 . 66 . 110+17 136±14 145±17 . 57 . 59 . 3
Sham 53 . 64 118±14 116±12 107±12 . 32 . 41 . 4
Untouched 52 . 6 5 . 114±14 99±20 99±23 . 35 . 30 . 3
DOCA
DOCA + sesame oil 19 . .. . 112±10 130± 8 140412 . 26 . 21 . 4
Sesame oil only 22 . .. . 109±12 107± 9 108±10 . 27 . 17 . 2
Untouched 20 . .. 110±14 110± 8 112±14 . 30 . 20 . 2
* At time of tumor cell injection
more extensive in the former. Fifty-nine per cent of such tumors was graded as
2 or 3+ in the hypertensive group, whereas only 41 % and 30 % of the sham-
operated and untouched controls revealed this degree ofinvolvement respectively.
On the other hand, the incidence and extent ofhepatic tumorgrowth was compar-
able in rats with DOCA hypertension and their respective controls, although the
level of hypertension in the former was similar to that observed in rats with
unilateral renal artery constriction.
No difference in rate ofgrowth ofsubcutaneous implants or incidence ofnodal
and pulmonary metastases was noted in rats with either renal or hormonal
hypertension and their respective controls (Table II).
No effect of tumor growth on blood pressure was observed in either hyper-
tensive or normotensive animals during the experimental period investigated.
Estimates ofblood volume were comparable in rats with renal hypertension with
orwithoutinjections oftumor cells aswell assham-operated anduntreated controls
(TableI).
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TABLE II.-Fffect ofRenal and DOCA-induced Hypertension on Subcutaneous Groulth and
Metastases of Walker Tumor Cells
Metastases
Blood pressure r A'_
A ~ 5 Lymph node Lung
No. Initial T.TC.It At death Day 1 cm.* % + % +
Renal artery constriction
Clip . 45 . 108±12 140±12 145±18 . 19-1±48 . 35 39
Sham . 28 . 111±14 117± 9 102±16 . 19-5±46 . 37 43
Untouched . 30 . 117±11 108±10 104±14 . 192±40 . 33 40
DOCA and saline
DOCA and saline . 15 . 110± 6 145±16 148±12 . 16-2±3-8 . 47 35
Sesame oil only . 20 . 112± 8 111±12 110±8 . 174±4-7 . 40 40
Untouched . 29 . 104±10 116± 8 108±12 1563-9 . 48 38
* Day tumor reached 1 cm. in diameter
t At time of tumor cell injection
DISCUSSION
The results of these experimental studies fail to support the view indicating
an inverse relationship between neoplastic disease and hypertension. Indeed, the
incidence and growth ofthe Walker tumor was increased in the liver ofrats with
renal hypertension but not in those with hypertension induced by the administra-
tion of DOCA. We have no explanation for this difference nor the mechanism
concerned with the augmentation observed in rats with renal hypertension. This
effect doesnot appearrelatedto increased bloodvolume, a situationwhich hasbeen
demonstrated previously in our laboratory to be associated with an increase in
such hepatic growths (Fisher and Fisher, 1966). Although hypertension is often
accompanied by an increase in blood volume, the latter in rats with the renal
form of hypertension, which is not sodium dependent (Fisher and Klein, 1963),
was comparable to that of controls. Since the degrees of hypertension were
comparable in DOCA-treated rats as well as those with renal artery constriction,
it appears unlikely that the divergent results noted are due to the hypertension
per se. Also, the findings in the rats with DOCA-induced hypertension contradict
the proposal of Pellanda (1964) relating the clinical dissociation of hypertension
and cancer to a deficiency ofmineralocorticoid secretion.
In no instance was the incidence or size of metastases increased in tumor-
bearing rats with hypertension. This militates against the view suggesting that
the hypertensive state represents an unfavourable milieu for tumor dissemination
(Pellanda, 1964). No effect of tumor growth on blood pressure oftumor-bearing
animals was noted, although admittedly the experiments were ofrelatively short
duration.
The dichotomy between clinical and this experimental study may reflect a
deficiency ofhorizontal human necropsy studies regarding the interrelationship of
two disease states. Mainland (1953) has emphasized the need for vertical and
experimental studies to substantiate interpretations derived from such clinical
studies. Although the experimental model used also exhibits dissimilarities from
the clinical situation, notably thatthe effects ofrenal and mineralocorticoid rather
than essential hypertension on tumor growth were investigated and the tumor
was transplanted rather than spontaneous, nevertheless our findings warrant some
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degree of skepticism concerning the view suggesting a significant relationship
between hypertension and cancer.
SUMMARY
Hypertension induced by renal artery constriction or the administration of
DOCA failed to influence the subcutaneous growth or metastases oftransplanted
Walker tumors in rats. Hepatic growth, but not metastases, was increased in
those with renal hypertension. Tumor growth had no effect on blood pressure.
These experimental findings provoke skepticism concerning the view basedlargely
upon clinical studies which suggest an inverse relationship between hypertension
and neoplastic disease.
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